Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

269 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Plerixafor added to G-CSF-supported paclitaxel-ifosfamide-cisplatin salvage chemotherapy enhances mobilization of adequate numbers of hematopoietic stem cells for subsequent autografting in hard-to-mobilize patients with relapsed/refractory germ-cell tumors: a single-center experience.
Kosmas C, Athanasopoulos A, Dimitriadis G, Miltiadous C, Zilakos M, Lydakis D, Magiorkinis E, Gekas C, Daladimos T, Mylonakis N, Ziras N. Kosmas C, et al. Anticancer Drugs. 2014 Aug;25(7):841-7. doi: 10.1097/CAD.0000000000000100. Anticancer Drugs. 2014. PMID: 24625457
Plerixafor mobilization of peripheral blood hematopoietic progenitors to support further high-dose chemotherapy cycles in a patient with germ-cell tumor relapsing after previous tandem high-dose chemotherapy and hematopoietic cell transplantation: report of a case.
Miltiadous C, Dimitriadis GK, Roditis P, Kosmas C. Miltiadous C, et al. Among authors: kosmas c. Anticancer Drugs. 2017 Feb;28(2):237-241. doi: 10.1097/CAD.0000000000000444. Anticancer Drugs. 2017. PMID: 27749622
Myeloablative chemotherapy and autologous stem cell transplantation can lead to successful postengraftment mobilization of hematopoietic progenitors to support planned subsequent cycle(s) of high-dose chemotherapy and autografting in a patient with relapsed germ-cell tumor.
Fergadis E, Gavrielatou N, Skouteris N, Athanasopoulos A, Lianos E, Kosmas C. Fergadis E, et al. Among authors: kosmas c. Anticancer Drugs. 2019 Feb;30(2):205-208. doi: 10.1097/CAD.0000000000000714. Anticancer Drugs. 2019. PMID: 30489289
Plerixafor-aided Mobilization of Peripheral Blood Hematopoietic Stem Cells to Support Subsequent High-dose Chemotherapy After a Prior Autologous Transplant.
Fergadis E, Assi A, Kranidioti E, Kosma A, Karakosta M, Miltiadous C, Dimitriadis GK, Grivas A, Athanasopoulos A, Lianos E, Kosmas C. Fergadis E, et al. Among authors: kosmas c. Clin Lymphoma Myeloma Leuk. 2020 Feb;20(2):e50-e57. doi: 10.1016/j.clml.2019.11.022. Epub 2019 Dec 6. Clin Lymphoma Myeloma Leuk. 2020. PMID: 31884151
269 results